Sanofi to acquire Qunol for $1.4 billion

• Qunol is headquartered in Pine Brook, New Jersey. 
• The company's products are manufactured in the United States, and the ingredients come from the USA, Germany, India, Brazil, Japan, Malaysia, and China.  

July 27, 2023 Sanofi to acquire Qunol^®, a fast-growing U.S. brand in the healthy aging segment

• Transaction brings Qunol^®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. portfolio 
• Addition of Qunol’s CoQ10 and Turmeric products strengthens Sanofi’s CHC Vitamin, Mineral and Supplements category, one of the largest and fastest-growing consumer health categories in the U.S.

Paris, July 28, 2023. Sanofi announces today it has entered into a definitive agreement to acquire ownership of Qunol^®, a U.S.-based, market-leading brand in health & wellness. This transaction will strengthen Sanofi’s Consumer Healthcare’s (CHC) Vitamin, Mineral and Supplements (VMS) category, one of the largest and fastest-growing consumer health categories in the U.S., focusing on the active ‘healthy aging’ segment. With Qunol’s CoQ10 in heart health and Turmeric in joint health, CHC at Sanofi adds a trusted, profitable double-digit growth brand to its U.S. portfolio, focused on chronic conditions with growing consumer demand. With this acquisition, Sanofi continues to pursue growth opportunities and value creation for its consumer healthcare business.